Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Heart Rhythm|October 22, 2008
Epidemiology and outcomes in patients with atrial fibrillation in the United StatesAlexander M Walker, Dimitri BennettInquiry : a Journal of Medical Care Organization, Provision and Financing|November 21, 2019
Identifying Patients With Inflammatory Bowel Diseases in an Administrative Health Claims Database: Do Algorithms Generate Similar Findings?Yizhou Ye, Sudhakar Manne, Dimitri BennettBMC Public Health|June 2, 2011
Characteristics of patients with venous thromboembolism and atrial fibrillation in VenezuelaDimitri Bennett, Jorge Abate, Page E AbrahamsonAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 29, 2010
Predictors of warfarin use in atrial fibrillation patients in the inpatient settingShuchita Agarwal, Dimitri Bennett, David J SmithInflammatory Bowel Diseases|September 11, 2019
Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016Yizhou Ye, Sudhakar Manne, William R Treem, et al.Advances in Therapy|December 6, 2011
Prevalence of diagnosed adult immune thrombocytopenia in the United KingdomDimitri Bennett, M Elizabeth Hodgson, Amit Shukla, et al.Drugs - Real World Outcomes|August 4, 2019
Post-authorisation Safety Study of Pioglitazone Use and Safety Endpoints of Interest in Denmark After Direct Healthcare Professional CommunicationJavier Cid Ruzafa, Sinna Pilgaard Ulrichsen, Dimitri Bennett, et al.BMJ Open Diabetes Research & Care|January 12, 2017
Evaluation of exposure to pioglitazone and risk of prostate cancer: a nested case-control studyNaomi Boxall, Dimitri Bennett, Matthias Hunger, et al.European Journal of Haematology|May 21, 2016
Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysisIndraraj Umesh Doobaree, Raghava Nandigam, Dimitri Bennett, et al.Diabetology International|January 4, 2019
Association between therapy with dipeptidyl peptidase-4 (DPP-4) inhibitors and risk of ileus: a cohort studyDimitri Bennett, Shreya Davé, Motonobu Sakaguchi, et al.Pageof 6